Protagonist Therapeutics Stock Price on January 4, 2024
| PTGX Stock | USD 49.44 0.12 0.24% |
Below is the normalized historical share price chart for Protagonist Therapeutics extending back to August 11, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Protagonist Therapeutics stands at 49.44, as last reported on the 27th of March, with the highest price reaching 50.52 and the lowest price hitting 49.33 during the day.
If you're considering investing in Protagonist Stock, it is important to understand the factors that can impact its price. Protagonist Therapeutics appears to be not too volatile, given 3 months investment horizon. Protagonist Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0865, which implies the firm had a 0.0865 % return per unit of risk over the last 3 months. By analyzing Protagonist Therapeutics' technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please evaluate Protagonist Therapeutics' Coefficient Of Variation of 1201.27, risk adjusted performance of 0.079, and Semi Deviation of 2.45 to confirm if our risk estimates are consistent with your expectations.
At this time, Protagonist Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 782 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 33.6 M in 2025. . At this time, Protagonist Therapeutics' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 3.70 in 2025, whereas Price To Sales Ratio is likely to drop 5.20 in 2025. Protagonist Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of August 2016 | 200 Day MA 41.1124 | 50 Day MA 41.7728 | Beta 2.33 |
Protagonist |
Sharpe Ratio = 0.0865
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PTGX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.42 actual daily | 57 57% of assets are less volatile |
Expected Return
| 0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Protagonist Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Protagonist Therapeutics by adding it to a well-diversified portfolio.
Price Book 4.6404 | Enterprise Value Ebitda 10.6579 | Price Sales 7.4224 | Shares Float 49.3 M | Wall Street Target Price 69.1 |
Protagonist Therapeutics Main Headline on 4th of January 2024
Acquisition by Dinesh Patel of 84875 shares of Protagonist T... by Dinesh Patel
Filed transaction by Protagonist Therapeutics director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Protagonist Therapeutics Valuation on January 4, 2024
It is possible to determine the worth of Protagonist Therapeutics on a given historical date. On January 4, 2024 Protagonist was worth 22.68 at the beginning of the trading date compared to the closed value of 22.82. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Protagonist Therapeutics stock. Still, in general, we apply an absolute valuation method to find Protagonist Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Protagonist Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Protagonist Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 23.38 | 23.38 | 22.30 | 22.55 | 633,069 | |
01/04/2024 | 22.68 | 23.64 | 22.44 | 22.82 | 540,280 |
| 22.70 | 22.79 | 21.43 | 21.79 | 775,535 |
| Backtest Protagonist Therapeutics | | | Protagonist Therapeutics History | | | Protagonist Therapeutics Valuation | Previous | Next |
Protagonist Therapeutics Trading Date Momentum on January 4, 2024
| On January 05 2024 Protagonist Therapeutics was traded for 21.79 at the closing time. The top price for the day was 22.79 and the lowest listed price was 21.43 . The trading volume for the day was 775.5 K. The trading history from January 5, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 4.51% . The trading delta at closing time against the current closing price is 12.31% . |
Protagonist Therapeutics Fundamentals Correlations and Trends
By evaluating Protagonist Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Protagonist Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Protagonist financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Protagonist Therapeutics Stock history
Protagonist Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Protagonist is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Protagonist Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Protagonist Therapeutics stock prices may prove useful in developing a viable investing in Protagonist Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 65.1 M | 33.6 M | |
| Net Loss | -114.7 M | -108.9 M |
Protagonist Therapeutics Quarterly Net Working Capital |
|
Protagonist Therapeutics Stock Technical Analysis
Protagonist Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Protagonist Therapeutics Period Price Range
Low | March 27, 2025
| High |
0.00 | 0.00 |
Protagonist Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Protagonist Therapeutics March 27, 2025 Market Strength
Market strength indicators help investors to evaluate how Protagonist Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protagonist Therapeutics shares will generate the highest return on investment. By undertsting and applying Protagonist Therapeutics stock market strength indicators, traders can identify Protagonist Therapeutics entry and exit signals to maximize returns
Protagonist Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Protagonist Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Protagonist Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Protagonist to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.079 | |||
| Jensen Alpha | 0.5034 | |||
| Total Risk Alpha | 0.5258 | |||
| Sortino Ratio | 0.1912 | |||
| Treynor Ratio | (0.29) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.